[Federal Register Volume 85, Number 58 (Wednesday, March 25, 2020)]
[Notices]
[Page 16945]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06249]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Clinical Laboratory Improvement Advisory Committee (CLIAC);
Cancellation of Meeting
Notice is hereby given of a change in the meeting of the Clinical
Laboratory Improvement Advisory Committee (CLIAC); April 16, 2020, 8:30
a.m. to 5:00 p.m., EDT and April 17, 2020, 8:30 a.m. to 11:30 a.m.,
EDT, in the original FRN. Food and Drug Administration (FDA), White Oak
Campus, 10903 New Hampshire Avenue, Building 31, Great Room, Silver
Spring, Maryland 20993 and via webcast at www.cdc.gov/cliac which was
published in the Federal Register on February 28, 2020, Volume 85,
Number 40, page 11993.
This meeting is being canceled in its entirety.
FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Senior
Advisor for Clinical Laboratories, Division of Laboratory Systems,
Center for Surveillance, Epidemiology and Laboratory Services, Office
of Public Health Scientific Services, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop V24-3, Atlanta, Georgia
30329-4027, telephone (404) 498-2741; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-06249 Filed 3-24-20; 8:45 am]
BILLING CODE 4163-18-P